ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurogenic Detrusor Overactivity(NDO) Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-3Y15904
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Neurogenic Detrusor Overactivity NDO Market Research Report 2023
BUY CHAPTERS

Global Neurogenic Detrusor Overactivity(NDO) Market Research Report 2025

Code: QYRE-Auto-3Y15904
Report
May 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astellas Pharma
AbbVie
Medtronic Inc

Neurogenic Detrusor Overactivity(NDO) Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Neurogenic Detrusor Overactivity(NDO) Market

Neurogenic Detrusor Overactivity(NDO) Market

The global market for Neurogenic Detrusor Overactivity(NDO) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
NDO is a subtype of neurogenic lower urinary tract symptoms that are often caused by neurological disorders, including spinal cord injury, multiple sclerosis, and Parkinson"s disease. Clinical manifestations include increased daytime urinary frequency, urinary urgency, and acute urinary incontinence, which seriously affects the patient"s quality of life.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neurogenic Detrusor Overactivity(NDO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurogenic Detrusor Overactivity(NDO).
The Neurogenic Detrusor Overactivity(NDO) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurogenic Detrusor Overactivity(NDO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurogenic Detrusor Overactivity(NDO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Neurogenic Detrusor Overactivity(NDO) Market Report

Report Metric Details
Report Name Neurogenic Detrusor Overactivity(NDO) Market
CAGR 5%
Segment by Type
  • Non-surgical Treatment
  • Surgical Treatment
  • Follow-up Treatment
Segment by Application
  • Aldult
  • Child
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Astellas Pharma, AbbVie, Medtronic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Neurogenic Detrusor Overactivity(NDO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Neurogenic Detrusor Overactivity(NDO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Neurogenic Detrusor Overactivity(NDO) Market report?

Ans: The main players in the Neurogenic Detrusor Overactivity(NDO) Market are Astellas Pharma, AbbVie, Medtronic

What are the Application segmentation covered in the Neurogenic Detrusor Overactivity(NDO) Market report?

Ans: The Applications covered in the Neurogenic Detrusor Overactivity(NDO) Market report are Aldult, Child

What are the Type segmentation covered in the Neurogenic Detrusor Overactivity(NDO) Market report?

Ans: The Types covered in the Neurogenic Detrusor Overactivity(NDO) Market report are Non-surgical Treatment, Surgical Treatment, Follow-up Treatment

1 Neurogenic Detrusor Overactivity(NDO) Market Overview
1.1 Product Definition
1.2 Neurogenic Detrusor Overactivity(NDO) by Type
1.2.1 Global Neurogenic Detrusor Overactivity(NDO) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Non-surgical Treatment
1.2.3 Surgical Treatment
1.2.4 Follow-up Treatment
1.3 Neurogenic Detrusor Overactivity(NDO) by Application
1.3.1 Global Neurogenic Detrusor Overactivity(NDO) Market Value by Application (2024 VS 2031)
1.3.2 Aldult
1.3.3 Child
1.4 Global Neurogenic Detrusor Overactivity(NDO) Market Size Estimates and Forecasts
1.4.1 Global Neurogenic Detrusor Overactivity(NDO) Revenue 2020-2031
1.4.2 Global Neurogenic Detrusor Overactivity(NDO) Sales 2020-2031
1.4.3 Global Neurogenic Detrusor Overactivity(NDO) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Neurogenic Detrusor Overactivity(NDO) Market Competition by Manufacturers
2.1 Global Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Neurogenic Detrusor Overactivity(NDO) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Neurogenic Detrusor Overactivity(NDO), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurogenic Detrusor Overactivity(NDO), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurogenic Detrusor Overactivity(NDO), Product Type & Application
2.7 Global Key Manufacturers of Neurogenic Detrusor Overactivity(NDO), Date of Enter into This Industry
2.8 Global Neurogenic Detrusor Overactivity(NDO) Market Competitive Situation and Trends
2.8.1 Global Neurogenic Detrusor Overactivity(NDO) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Neurogenic Detrusor Overactivity(NDO) Players Market Share by Revenue
2.8.3 Global Neurogenic Detrusor Overactivity(NDO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neurogenic Detrusor Overactivity(NDO) Market Scenario by Region
3.1 Global Neurogenic Detrusor Overactivity(NDO) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Neurogenic Detrusor Overactivity(NDO) Sales by Region: 2020-2031
3.2.1 Global Neurogenic Detrusor Overactivity(NDO) Sales by Region: 2020-2025
3.2.2 Global Neurogenic Detrusor Overactivity(NDO) Sales by Region: 2026-2031
3.3 Global Neurogenic Detrusor Overactivity(NDO) Revenue by Region: 2020-2031
3.3.1 Global Neurogenic Detrusor Overactivity(NDO) Revenue by Region: 2020-2025
3.3.2 Global Neurogenic Detrusor Overactivity(NDO) Revenue by Region: 2026-2031
3.4 North America Neurogenic Detrusor Overactivity(NDO) Market Facts & Figures by Country
3.4.1 North America Neurogenic Detrusor Overactivity(NDO) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Neurogenic Detrusor Overactivity(NDO) Sales by Country (2020-2031)
3.4.3 North America Neurogenic Detrusor Overactivity(NDO) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurogenic Detrusor Overactivity(NDO) Market Facts & Figures by Country
3.5.1 Europe Neurogenic Detrusor Overactivity(NDO) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Neurogenic Detrusor Overactivity(NDO) Sales by Country (2020-2031)
3.5.3 Europe Neurogenic Detrusor Overactivity(NDO) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurogenic Detrusor Overactivity(NDO) Market Facts & Figures by Region
3.6.1 Asia Pacific Neurogenic Detrusor Overactivity(NDO) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Neurogenic Detrusor Overactivity(NDO) Sales by Region (2020-2031)
3.6.3 Asia Pacific Neurogenic Detrusor Overactivity(NDO) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Neurogenic Detrusor Overactivity(NDO) Market Facts & Figures by Country
3.7.1 Latin America Neurogenic Detrusor Overactivity(NDO) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Neurogenic Detrusor Overactivity(NDO) Sales by Country (2020-2031)
3.7.3 Latin America Neurogenic Detrusor Overactivity(NDO) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurogenic Detrusor Overactivity(NDO) Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurogenic Detrusor Overactivity(NDO) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Neurogenic Detrusor Overactivity(NDO) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Neurogenic Detrusor Overactivity(NDO) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurogenic Detrusor Overactivity(NDO) Sales by Type (2020-2031)
4.1.1 Global Neurogenic Detrusor Overactivity(NDO) Sales by Type (2020-2025)
4.1.2 Global Neurogenic Detrusor Overactivity(NDO) Sales by Type (2026-2031)
4.1.3 Global Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Type (2020-2031)
4.2 Global Neurogenic Detrusor Overactivity(NDO) Revenue by Type (2020-2031)
4.2.1 Global Neurogenic Detrusor Overactivity(NDO) Revenue by Type (2020-2025)
4.2.2 Global Neurogenic Detrusor Overactivity(NDO) Revenue by Type (2026-2031)
4.2.3 Global Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Type (2020-2031)
4.3 Global Neurogenic Detrusor Overactivity(NDO) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Neurogenic Detrusor Overactivity(NDO) Sales by Application (2020-2031)
5.1.1 Global Neurogenic Detrusor Overactivity(NDO) Sales by Application (2020-2025)
5.1.2 Global Neurogenic Detrusor Overactivity(NDO) Sales by Application (2026-2031)
5.1.3 Global Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Application (2020-2031)
5.2 Global Neurogenic Detrusor Overactivity(NDO) Revenue by Application (2020-2031)
5.2.1 Global Neurogenic Detrusor Overactivity(NDO) Revenue by Application (2020-2025)
5.2.2 Global Neurogenic Detrusor Overactivity(NDO) Revenue by Application (2026-2031)
5.2.3 Global Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Application (2020-2031)
5.3 Global Neurogenic Detrusor Overactivity(NDO) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Astellas Pharma
6.1.1 Astellas Pharma Company Information
6.1.2 Astellas Pharma Description and Business Overview
6.1.3 Astellas Pharma Neurogenic Detrusor Overactivity(NDO) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Astellas Pharma Neurogenic Detrusor Overactivity(NDO) Product Portfolio
6.1.5 Astellas Pharma Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Neurogenic Detrusor Overactivity(NDO) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AbbVie Neurogenic Detrusor Overactivity(NDO) Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Neurogenic Detrusor Overactivity(NDO) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Medtronic Neurogenic Detrusor Overactivity(NDO) Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurogenic Detrusor Overactivity(NDO) Industry Chain Analysis
7.2 Neurogenic Detrusor Overactivity(NDO) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurogenic Detrusor Overactivity(NDO) Production Mode & Process Analysis
7.4 Neurogenic Detrusor Overactivity(NDO) Sales and Marketing
7.4.1 Neurogenic Detrusor Overactivity(NDO) Sales Channels
7.4.2 Neurogenic Detrusor Overactivity(NDO) Distributors
7.5 Neurogenic Detrusor Overactivity(NDO) Customer Analysis
8 Neurogenic Detrusor Overactivity(NDO) Market Dynamics
8.1 Neurogenic Detrusor Overactivity(NDO) Industry Trends
8.2 Neurogenic Detrusor Overactivity(NDO) Market Drivers
8.3 Neurogenic Detrusor Overactivity(NDO) Market Challenges
8.4 Neurogenic Detrusor Overactivity(NDO) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astellas Pharma
AbbVie
Medtronic Inc
List of Tables
 Table 1. Global Neurogenic Detrusor Overactivity(NDO) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Neurogenic Detrusor Overactivity(NDO) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Neurogenic Detrusor Overactivity(NDO) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Neurogenic Detrusor Overactivity(NDO) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Neurogenic Detrusor Overactivity(NDO) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Neurogenic Detrusor Overactivity(NDO) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Neurogenic Detrusor Overactivity(NDO) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Neurogenic Detrusor Overactivity(NDO), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Neurogenic Detrusor Overactivity(NDO), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Neurogenic Detrusor Overactivity(NDO), Product Type & Application
 Table 12. Global Key Manufacturers of Neurogenic Detrusor Overactivity(NDO), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Neurogenic Detrusor Overactivity(NDO) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurogenic Detrusor Overactivity(NDO) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Neurogenic Detrusor Overactivity(NDO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Neurogenic Detrusor Overactivity(NDO) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Region (2020-2025)
 Table 19. Global Neurogenic Detrusor Overactivity(NDO) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Region (2026-2031)
 Table 21. Global Neurogenic Detrusor Overactivity(NDO) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Region (2020-2025)
 Table 23. Global Neurogenic Detrusor Overactivity(NDO) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Region (2026-2031)
 Table 25. North America Neurogenic Detrusor Overactivity(NDO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Neurogenic Detrusor Overactivity(NDO) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Neurogenic Detrusor Overactivity(NDO) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Neurogenic Detrusor Overactivity(NDO) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Neurogenic Detrusor Overactivity(NDO) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Neurogenic Detrusor Overactivity(NDO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Neurogenic Detrusor Overactivity(NDO) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Neurogenic Detrusor Overactivity(NDO) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Neurogenic Detrusor Overactivity(NDO) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Neurogenic Detrusor Overactivity(NDO) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Neurogenic Detrusor Overactivity(NDO) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Neurogenic Detrusor Overactivity(NDO) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Neurogenic Detrusor Overactivity(NDO) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Neurogenic Detrusor Overactivity(NDO) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Neurogenic Detrusor Overactivity(NDO) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Neurogenic Detrusor Overactivity(NDO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Neurogenic Detrusor Overactivity(NDO) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Neurogenic Detrusor Overactivity(NDO) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Neurogenic Detrusor Overactivity(NDO) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Neurogenic Detrusor Overactivity(NDO) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Neurogenic Detrusor Overactivity(NDO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Neurogenic Detrusor Overactivity(NDO) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Neurogenic Detrusor Overactivity(NDO) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Neurogenic Detrusor Overactivity(NDO) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Neurogenic Detrusor Overactivity(NDO) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Neurogenic Detrusor Overactivity(NDO) Sales (K Units) by Type (2020-2025)
 Table 51. Global Neurogenic Detrusor Overactivity(NDO) Sales (K Units) by Type (2026-2031)
 Table 52. Global Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Type (2020-2025)
 Table 53. Global Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Type (2026-2031)
 Table 54. Global Neurogenic Detrusor Overactivity(NDO) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Neurogenic Detrusor Overactivity(NDO) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Type (2020-2025)
 Table 57. Global Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Type (2026-2031)
 Table 58. Global Neurogenic Detrusor Overactivity(NDO) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Neurogenic Detrusor Overactivity(NDO) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Neurogenic Detrusor Overactivity(NDO) Sales (K Units) by Application (2020-2025)
 Table 61. Global Neurogenic Detrusor Overactivity(NDO) Sales (K Units) by Application (2026-2031)
 Table 62. Global Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Application (2020-2025)
 Table 63. Global Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Application (2026-2031)
 Table 64. Global Neurogenic Detrusor Overactivity(NDO) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Neurogenic Detrusor Overactivity(NDO) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Application (2020-2025)
 Table 67. Global Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Application (2026-2031)
 Table 68. Global Neurogenic Detrusor Overactivity(NDO) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Neurogenic Detrusor Overactivity(NDO) Price (US$/Unit) by Application (2026-2031)
 Table 70. Astellas Pharma Company Information
 Table 71. Astellas Pharma Description and Business Overview
 Table 72. Astellas Pharma Neurogenic Detrusor Overactivity(NDO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Astellas Pharma Neurogenic Detrusor Overactivity(NDO) Product
 Table 74. Astellas Pharma Recent Developments/Updates
 Table 75. AbbVie Company Information
 Table 76. AbbVie Description and Business Overview
 Table 77. AbbVie Neurogenic Detrusor Overactivity(NDO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AbbVie Neurogenic Detrusor Overactivity(NDO) Product
 Table 79. AbbVie Recent Developments/Updates
 Table 80. Medtronic Company Information
 Table 81. Medtronic Description and Business Overview
 Table 82. Medtronic Neurogenic Detrusor Overactivity(NDO) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Medtronic Neurogenic Detrusor Overactivity(NDO) Product
 Table 84. Medtronic Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Neurogenic Detrusor Overactivity(NDO) Distributors List
 Table 88. Neurogenic Detrusor Overactivity(NDO) Customers List
 Table 89. Neurogenic Detrusor Overactivity(NDO) Market Trends
 Table 90. Neurogenic Detrusor Overactivity(NDO) Market Drivers
 Table 91. Neurogenic Detrusor Overactivity(NDO) Market Challenges
 Table 92. Neurogenic Detrusor Overactivity(NDO) Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Neurogenic Detrusor Overactivity(NDO)
 Figure 2. Global Neurogenic Detrusor Overactivity(NDO) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Neurogenic Detrusor Overactivity(NDO) Market Share by Type: 2024 & 2031
 Figure 4. Non-surgical Treatment Product Picture
 Figure 5. Surgical Treatment Product Picture
 Figure 6. Follow-up Treatment Product Picture
 Figure 7. Global Neurogenic Detrusor Overactivity(NDO) Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Neurogenic Detrusor Overactivity(NDO) Market Share by Application: 2024 & 2031
 Figure 9. Aldult
 Figure 10. Child
 Figure 11. Global Neurogenic Detrusor Overactivity(NDO) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Neurogenic Detrusor Overactivity(NDO) Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Neurogenic Detrusor Overactivity(NDO) Sales (2020-2031) & (K Units)
 Figure 14. Global Neurogenic Detrusor Overactivity(NDO) Average Price (US$/Unit) & (2020-2031)
 Figure 15. Neurogenic Detrusor Overactivity(NDO) Report Years Considered
 Figure 16. Neurogenic Detrusor Overactivity(NDO) Sales Share by Manufacturers in 2024
 Figure 17. Global Neurogenic Detrusor Overactivity(NDO) Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Neurogenic Detrusor Overactivity(NDO) Players: Market Share by Revenue in Neurogenic Detrusor Overactivity(NDO) in 2024
 Figure 19. Neurogenic Detrusor Overactivity(NDO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Neurogenic Detrusor Overactivity(NDO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Country (2020-2031)
 Figure 22. North America Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Country (2020-2031)
 Figure 23. United States Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Country (2020-2031)
 Figure 26. Europe Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Region (2020-2031)
 Figure 34. China Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Neurogenic Detrusor Overactivity(NDO) Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Neurogenic Detrusor Overactivity(NDO) Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Neurogenic Detrusor Overactivity(NDO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Neurogenic Detrusor Overactivity(NDO) by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Neurogenic Detrusor Overactivity(NDO) by Type (2020-2031)
 Figure 53. Global Neurogenic Detrusor Overactivity(NDO) Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Neurogenic Detrusor Overactivity(NDO) by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Neurogenic Detrusor Overactivity(NDO) by Application (2020-2031)
 Figure 56. Global Neurogenic Detrusor Overactivity(NDO) Price (US$/Unit) by Application (2020-2031)
 Figure 57. Neurogenic Detrusor Overactivity(NDO) Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global OAB Treatment Market Research Report 2025
Global Overactive Bladder Drug Market Research Report 2024
Global Neurodegenerative Disease Treatment Market Research Report 2024
Global Neurodegenerative Disorder Therapeutics Market Research Report 2024
Global Neurodiagnostic Consumables Market Research Report 2024
Global Neurodiagnostic Devices Market Research Report 2024
Global Incontinence Management System Market Research Report 2025
Global Sacral Neuromodulation Device Market Research Report 2024
Global Urinary Incontinence Electrical Stimulation Device Market Research Report 2025
Global Severe Incontinence Products Market Research Report 2024
Global Neurostimulation and Neuromodulation Device Market Research Report 2024
Global Neurostimulator Device Market Research Report 2025
Internal Neuromodulation Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurostimulator Medical Device Market Research Report 2024
Global Deep Brain Stimulation and Service for Parkinson s Disease Market Research Report 2024
Global Renal Denervation RDN Therapy Market Research Report 2024
Global Tibial Neuromodulation Devices Market Research Report 2024
Global Internal Urinary Incontinence Device Market Research Report 2025
Global Digital Therapy for Urinary Incontinence Market Research Report 2024
Global Overactive Bladder Medication Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions